Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: A phase Ib dose-finding study

S. De Vos*, L. J. Swinnen, D. Wang, E. Reid, N. Fowler, J. Cordero, M. Dunbar, S. H. Enschede, C. Nolan, A. M. Petrich, J. A. Ross, A. H. Salem, M. Verdugo, S. Agarwal, L. Zhou, M. Kozloff, L. J. Nastoupil, C. R. Flowers

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Fingerprint

Dive into the research topics of 'Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: A phase Ib dose-finding study'. Together they form a unique fingerprint.

Medicine & Life Sciences